Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51

PHASE3CompletedINTERVENTIONAL

Enrollment

639

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

September 30, 2007

Conditions

Japanese Encephalitis

Interventions

BIOLOGICAL

IC51

6 mcg, intramuscularly \[i.m.\], 0.5 mL

All Listed Sponsors

lead

Valneva Austria GmbH

INDUSTRY

NCT00594958 - Comparison of Three Batches of the Japanese Encephalitis Vaccine IC51 | Biotech Hunter | Biotech Hunter